Life Science News

- Johnson & Johnson (NYSE: JNJ) will participate in Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23 rd Ashley McEvoy Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time) .

This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com .

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

(PRNewsfoto/Johnson & Johnson)

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-citis-2022-virtual-healthcare-conference-301470256.html

SOURCE Johnson & Johnson

News Provided by PR Newswire via QuoteMedia

JNJ
Hot Chili Limited

Another High Grade Boost for Cortadera 658m at 0.6% CuEq including 130m at 0.9% CuEq

Hot Chili Limited (ASX: HCH) (TSXV: HCH) (OTCQX: HHLKF) (“Hot Chili” or “Company”) is pleased to report another outstanding drill result at the Cortadera porphyry deposit, part of the Company’s Costa Fuego, coastal range, copper-gold hub in Chile.

Highlights

Keep reading...Show less
Sarama Resources Ltd

West African Gold Explorer & Developer, Sarama Resources, Lists on ASX, Raises A$8M

Sarama Resources Ltd. (“Sarama” or the “Company”) (ASX:SRR, TSXV:SWA) is pleased to announce that the Company’s securities have commenced trading on the Australian Securities Exchange (“ASX”) under the ASX code SRR following a strongly supported public offering which saw A$8M raised predominantly from a broad base of domestic and international institutional and sophisticated investors.